Achieving Conduction System Activation With Leadless Left Ventricular Endocardial Pacing

NCT ID: NCT05659680

Last Updated: 2022-12-21

Basic Information

• Recruitment Status: UNKNOWN
• Clinical Phase: NA
• Total Enrollment: 15 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2023-01-31
• Study Completion Date: 2025-01-31

Brief Summary

The goal of this prospective non-randomised study is to test the feasibility of leadless conduction system pacing using the WiSE-CRT device in patients with an indication for Cardiac Resynchronisation Therapy.

The main question[s] it aims to answer are:

1. What is the safety profile of leadless conduction system pacing?

2. What is the success rate of leadless conduction system pacing?

3. What are the electrical and haemodynamic effects of leadless conduction system pacing.

Participants will undergo pre-procedural cardiac CT, and post-procedure electro-anatomical mapping and haemodynamic assessments.

Conditions

Heart Failure

Keywords

heart failure; cardiac resynchronisation therapy; leadless pacing

Study Design

• Allocation Method: NA
• Intervention Model: SINGLE_GROUP
• Primary Study Purpose: TREATMENT
• Blinding Strategy: NONE

Study Groups

Leadless Conduction System Pacing

Participants receive leadless conduction system pacing using the WiSE-CRT device.

Group Type: EXPERIMENTAL

WiSE-CRT

Intervention Type: DEVICE

Participants undergo pre-procedural CT, implantation of the WiSE-CRT system targeting the left bundle branch area, and post procedural non-invasive electro-anatomical mapping using electrocardiographic imaging and haemodynamic assessment.

Interventions

WiSE-CRT

Participants undergo pre-procedural CT, implantation of the WiSE-CRT system targeting the left bundle branch area, and post procedural non-invasive electro-anatomical mapping using electrocardiographic imaging and haemodynamic assessment.

Intervention Type: DEVICE

Other Intervention Names

WiSE CRT

Eligibility Criteria

Inclusion Criteria

• Age over 18 years
• Ability to provide informed consent to participate and willing to comply with the clinical investigation plan and follow-up schedule.
• Patients meeting European Society of Cardiology Criteria for Cardiac Resynchronization Therapy (CRT) with Class 1 or 2a recommendation:

• Dyssynchronous Heart Failure: Left Ventricular Ejection Fraction (LVEF) ≤35%, QRS duration >150ms or >130ms in presence of left bundle branch block (LBBB). Also included here are patients with EF ≤35%, an existing pacing system and an RV pacing burden of >20%.
• BLOCK HF population: Patients requiring pacing for atrioventricular (AV) block with an LVEF ≤50%
• AV node ablation (AVNA) population: Patients planned for AVNA with EF ≤50%.

Exclusion Criteria

• Any contraindication to LV endocardial pacing.

• LV thrombus
• Contra-indication to heparin
• Contra-indication to anti-platelet agents
• Failure of acoustic window screening
• Septal wall thickness <5mm (minimum required wall thickness at any target implant site)
• Myocardial infarction within 40 days prior to enrolment.
• Cardiac surgery or coronary revascularisation procedure within 3 months prior to enrolment or to be scheduled for such procedures within the following 7 months.
• Participation in other studies with active treatment/investigational arm.
• Pregnant or planning to become pregnant in the next 7 months.

• Minimum Eligible Age: 18 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

King's College London

OTHER

Sponsor Role: collaborator

Guy's and St Thomas' NHS Foundation Trust

OTHER

Sponsor Role: lead

Responsible Party

Responsibility Role: SPONSOR

Other Identifiers

307507

Identifier Type: -

Identifier Source: org_study_id